LIFECORE BIOMEDICAL, INC. Operating Expenses
LIFECORE BIOMEDICAL, INC. (LFCR) reported Operating Expenses of $13.04 million for the 3-month period ending 2024-11-24, per its 10-Q filed 2025-01-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2025-01-02
- LIFECORE BIOMEDICAL, INC. operating expenses for the quarter ending 2024-11-24 was $13.04M, a 14.01% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. operating expenses for the quarter ending 2024-08-25 was $16.97M, a 49.63% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. operating expenses for the quarter ending 2024-05-26 was $15.12M, a 4.90% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. operating expenses for the quarter ending 2024-02-25 was $12.79M, a 15.19% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. operating expenses for fiscal 2024 was $50.69M, a 1.83% increase from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. operating expenses for fiscal 2023 was $49.78M, a 2.12% decline from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. operating expenses for fiscal 2022 was $50.86M, a 6.48% increase from fiscal 2021.
- LIFECORE BIOMEDICAL, INC. operating expenses for fiscal 2021 was $47.76M, a 26.82% decline from fiscal 2020.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-11-24 | $13.04M 10-Q · filed 2025-01-02 | $30.01M 10-Q · filed 2025-01-02 | $45.14M derived: sum of 3 quarters · filed 2025-01-02 | $57.93M derived: sum of 4 quarters · filed 2025-01-02 | ||||
| 2024-08-25 | $16.97M 10-Q · filed 2024-10-04 | $32.09M derived: sum of 2 quarters · filed 2024-10-04 | $44.88M derived: sum of 3 quarters · filed 2024-10-04 | $56.32M derived: sum of 4 quarters · filed 2025-01-02 | ||||
| 2024-05-26 | $15.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $27.91M derived: sum of 2 quarters · filed 2024-08-26 | $39.35M derived: sum of 3 quarters · filed 2025-01-02 | $50.69M 10-K · filed 2024-08-26 | ||||
| 2024-02-25 | $12.79M 10-Q · filed 2024-08-09 | $24.23M derived: sum of 2 quarters · filed 2025-01-02 | $35.57M 10-Q · filed 2024-08-09 | $49.99M derived: sum of 4 quarters · filed 2025-01-02 | ||||
| 2023-11-26 | $11.44M 10-Q · filed 2025-01-02 | $22.78M 10-Q · filed 2025-01-02 | $37.20M derived: sum of 3 quarters · filed 2025-01-02 | $52.28M derived: sum of 4 quarters · filed 2025-01-02 | ||||
| 2023-08-27 | $11.34M 10-Q · filed 2024-10-04 | $25.76M derived: sum of 2 quarters · filed 2024-10-04 | $40.84M derived: sum of 3 quarters · filed 2024-10-04 | $51.87M derived: sum of 4 quarters · filed 2024-10-04 | ||||
| 2023-05-28 | $14.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $29.50M derived: sum of 2 quarters · filed 2024-08-26 | $40.53M derived: sum of 3 quarters · filed 2024-08-26 | $49.78M 10-K · filed 2024-08-26 | ||||
| 2023-02-26 | $15.08M 10-Q · filed 2024-08-09 | $15.68M 10-Q · filed 2023-06-02 | $26.11M derived: sum of 2 quarters · filed 2024-08-09 | $35.36M 10-Q · filed 2024-08-09 | $40.13M 10-Q · filed 2023-06-02 | $45.31M derived: sum of 4 quarters · filed 2024-08-26 | ||
| 2022-11-27 | $11.03M 10-Q · filed 2024-08-09 | $15.01M 10-Q · filed 2023-03-16 | $20.29M 10-Q · filed 2024-08-09 | $28.77M 10-Q · filed 2023-03-16 | $30.23M derived: sum of 3 quarters · filed 2024-08-26 | $51.51M derived: sum of 4 quarters · filed 2024-08-26 | ||
| 2022-08-28 | $9.25M 10-Q · filed 2024-08-09 | $13.98M 10-Q · filed 2022-10-07 | $19.20M derived: sum of 2 quarters · filed 2024-08-26 | $40.48M derived: sum of 3 quarters · filed 2024-08-26 | $48.24M derived: sum of 4 quarters · filed 2024-08-26 | |||
| 2022-05-29 | $9.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $31.22M derived: sum of 2 quarters · filed 2024-08-26 | $38.99M derived: sum of 3 quarters · filed 2024-08-26 | $50.86M 10-K · filed 2024-08-26 | $91.66M 10-K · filed 2022-09-14 | |||
| 2022-02-27 | $21.28M 10-K · filed 2024-03-20 | $17.65M 10-Q · filed 2022-04-07 | $29.05M derived: sum of 2 quarters · filed 2024-03-20 | $40.91M 10-Q · filed 2023-06-02 | $41.40M 10-Q · filed 2022-04-07 | $48.49M derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2021-11-28 | $7.77M 10-K · filed 2024-03-20 | $50.02M 10-Q · filed 2022-01-07 | $23.75M 10-Q · filed 2023-03-16 | $71.35M 10-Q · filed 2022-01-07 | $27.22M derived: sum of 3 quarters · filed 2024-03-20 | $38.07M derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2021-08-29 | $9.77M 10-K · filed 2024-03-20 | $21.33M 10-Q · filed 2021-10-05 | $19.45M derived: sum of 2 quarters · filed 2024-03-20 | $30.30M derived: sum of 3 quarters · filed 2024-03-20 | $39.70M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2021-05-30 | $9.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $20.54M derived: sum of 2 quarters · filed 2024-03-20 | $29.94M derived: sum of 3 quarters · filed 2024-03-20 | $47.76M 10-K · filed 2024-03-20 | $94.97M 10-K · filed 2021-07-29 | |||
| 2021-02-28 | $10.86M 10-K · filed 2024-03-20 | $20.48M 10-Q · filed 2021-04-08 | $20.26M derived: sum of 2 quarters · filed 2024-03-20 | $38.08M 10-Q · filed 2022-04-07 | $71.40M 10-Q · filed 2021-04-08 | $25.09M derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2020-11-29 | $9.40M 10-K · filed 2024-03-20 | $22.10M 10-Q · filed 2021-01-07 | $50.92M 10-Q · filed 2022-01-07 | $14.23M derived: sum of 3 quarters · filed 2024-03-20 | $49.29M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2020-08-30 | $15.90M 10-K · filed 2024-03-20 | $28.82M 10-Q · filed 2020-10-07 | $4.83M derived: sum of 2 quarters · filed 2024-03-20 | $39.89M derived: sum of 3 quarters · filed 2024-03-20 | $61.44M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2020-05-31 | -$11.06M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $24.00M derived: sum of 2 quarters · filed 2023-03-16 | $45.55M derived: sum of 3 quarters · filed 2023-03-16 | $65.26M 10-K/A · filed 2023-03-16 | $113.53M 10-K · filed 2020-08-14 | |||
| 2020-02-23 | $35.06M 10-Q · filed 2021-04-08 | $56.61M derived: sum of 2 quarters · filed 2021-04-08 | $76.32M 10-Q · filed 2021-04-08 | $100.06M derived: sum of 4 quarters · filed 2021-07-29 | ||||
| 2019-11-24 | $21.55M 10-Q · filed 2021-01-07 | $41.27M 10-Q · filed 2021-01-07 | $65.00M derived: sum of 3 quarters · filed 2021-07-29 | $83.33M derived: sum of 4 quarters · filed 2021-07-29 | ||||
| 2019-08-25 | $19.72M 10-Q · filed 2020-10-07 | $43.45M derived: sum of 2 quarters · filed 2021-07-29 | $61.77M derived: sum of 3 quarters · filed 2021-07-29 | $78.65M derived: sum of 4 quarters · filed 2021-07-29 | ||||
| 2019-05-26 | $23.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $42.06M derived: sum of 2 quarters · filed 2021-07-29 | $58.93M derived: sum of 3 quarters · filed 2021-07-29 | $75.53M 10-K · filed 2021-07-29 | ||||
| 2019-02-24 | $18.33M 10-Q · filed 2020-04-03 | $18.58M 10-Q · filed 2019-04-04 | $35.20M derived: sum of 2 quarters · filed 2020-04-03 | $51.80M 10-Q · filed 2020-04-03 | $52.57M 10-Q · filed 2019-04-04 | $68.53M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2018-11-25 | $16.88M 10-Q · filed 2020-01-02 | $17.20M 10-Q · filed 2019-01-07 | $33.47M 10-Q · filed 2020-01-02 | $33.98M 10-Q · filed 2019-01-07 | $50.21M derived: sum of 3 quarters · filed 2020-08-14 | $66.53M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2018-08-26 | $16.59M 10-Q · filed 2019-10-03 | $16.78M 10-Q · filed 2018-10-05 | $33.33M derived: sum of 2 quarters · filed 2020-08-14 | $49.65M derived: sum of 3 quarters · filed 2020-08-14 | $65.27M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2018-05-27 | $16.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $33.06M derived: sum of 2 quarters · filed 2020-08-14 | $48.67M derived: sum of 3 quarters · filed 2020-08-14 | $64.75M 10-K · filed 2020-08-14 | ||||
| 2018-02-25 | $16.32M 10-Q · filed 2019-04-04 | $16.92M 10-Q · filed 2018-04-05 | $31.94M derived: sum of 2 quarters · filed 2019-04-04 | $48.01M 10-Q · filed 2019-04-04 | $49.99M 10-Q · filed 2018-04-05 | $62.09M derived: sum of 4 quarters · filed 2019-08-01 | ||
| 2017-11-26 | $15.62M 10-Q · filed 2019-01-07 | $16.31M 10-Q · filed 2018-01-05 | $31.69M 10-Q · filed 2019-01-07 | $33.07M 10-Q · filed 2018-01-05 | $45.77M derived: sum of 3 quarters · filed 2019-08-01 | $64.87M derived: sum of 4 quarters · filed 2019-08-01 | ||
| 2017-08-27 | $16.08M 10-Q · filed 2018-10-05 | $16.76M 10-Q · filed 2017-09-28 | $30.16M derived: sum of 2 quarters · filed 2019-08-01 | $49.26M derived: sum of 3 quarters · filed 2019-08-01 | $64.95M derived: sum of 4 quarters · filed 2019-08-01 | |||
| 2017-05-28 | $14.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | $33.18M derived: sum of 2 quarters · filed 2019-08-01 | $48.87M derived: sum of 3 quarters · filed 2019-08-01 | $64.54M 10-K · filed 2019-08-01 | $67.68M 10-K · filed 2017-08-11 | |||
| 2017-02-26 | $19.10M 10-Q · filed 2018-04-05 | $34.79M derived: sum of 2 quarters · filed 2018-04-05 | $50.47M 10-Q · filed 2018-04-05 | $62.82M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2016-11-27 | $15.69M 10-Q · filed 2018-01-05 | $31.36M 10-Q · filed 2018-01-05 | $43.72M derived: sum of 3 quarters · filed 2018-08-09 | $90.28M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2016-08-28 | $15.67M 10-Q · filed 2017-09-28 | $28.03M derived: sum of 2 quarters · filed 2018-08-09 | $74.59M derived: sum of 3 quarters · filed 2018-08-09 | $89.04M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2016-05-29 | $12.36M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | $58.91M derived: sum of 2 quarters · filed 2018-08-09 | $73.37M derived: sum of 3 quarters · filed 2018-08-09 | $87.41M 10-K · filed 2018-08-09 | $90.74M 10-K · filed 2016-08-01 | |||
| 2016-02-28 | $46.55M 10-Q · filed 2017-04-07 | $61.01M derived: sum of 2 quarters · filed 2017-04-07 | $75.05M 10-Q · filed 2017-04-07 | $87.52M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-11-29 | $14.46M 10-Q · filed 2017-01-05 | $28.50M 10-Q · filed 2017-01-05 | $40.96M derived: sum of 3 quarters · filed 2018-03-15 | $53.02M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-08-30 | $14.04M 10-Q · filed 2016-09-29 | $26.50M derived: sum of 2 quarters · filed 2018-03-15 | $38.56M derived: sum of 3 quarters · filed 2018-03-15 | $50.33M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-05-31 | $12.46M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | $24.52M derived: sum of 2 quarters · filed 2018-03-15 | $36.29M derived: sum of 3 quarters · filed 2018-03-15 | $46.95M 10-K/A · filed 2018-03-15 | ||||
| 2015-03-01 | $12.05M 10-Q · filed 2016-03-30 | $23.83M derived: sum of 2 quarters · filed 2016-03-30 | $34.48M 10-Q · filed 2016-03-30 | $45.32M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2014-11-30 | $11.77M 10-Q · filed 2016-01-07 | $22.43M 10-Q · filed 2016-01-07 | $33.27M derived: sum of 3 quarters · filed 2016-08-01 | $43.69M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2014-08-31 | $10.65M 10-Q · filed 2015-10-01 | $21.49M derived: sum of 2 quarters · filed 2016-08-01 | $31.91M derived: sum of 3 quarters · filed 2016-08-01 | $42.47M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2014-05-25 | $10.84M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $21.26M derived: sum of 2 quarters · filed 2016-08-01 | $31.82M derived: sum of 3 quarters · filed 2016-08-01 | $42.37M 10-K · filed 2016-08-01 | ||||
| 2014-02-23 | $10.42M 10-Q · filed 2015-04-02 | $20.98M derived: sum of 2 quarters · filed 2015-04-02 | $31.54M 10-Q · filed 2015-04-02 | $40.45M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-11-24 | $10.56M 10-Q · filed 2015-01-09 | $21.11M 10-Q · filed 2015-01-09 | $30.03M derived: sum of 3 quarters · filed 2015-07-31 | $40.88M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-08-25 | $10.56M 10-Q · filed 2014-10-08 | $19.47M derived: sum of 2 quarters · filed 2015-07-31 | $30.32M derived: sum of 3 quarters · filed 2015-07-31 | $37.69M derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-05-26 | $8.92M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $19.77M derived: sum of 2 quarters · filed 2015-07-31 | $27.13M derived: sum of 3 quarters · filed 2015-07-31 | $37.89M 10-K · filed 2015-07-31 | ||||
| 2013-02-24 | $10.85M 10-Q · filed 2014-03-28 | $18.21M derived: sum of 2 quarters · filed 2014-03-28 | $28.98M 10-Q · filed 2014-03-28 | $40.22M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-11-25 | $7.37M 10-Q · filed 2014-01-03 | $18.13M 10-Q · filed 2014-01-03 | $29.37M derived: sum of 3 quarters · filed 2014-08-01 | $38.51M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-08-26 | $10.76M 10-Q · filed 2013-09-26 | $22.01M derived: sum of 2 quarters · filed 2014-08-01 | $31.14M derived: sum of 3 quarters · filed 2014-08-01 | $39.95M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-05-27 | $11.25M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $20.38M derived: sum of 2 quarters · filed 2014-08-01 | $29.18M derived: sum of 3 quarters · filed 2014-08-01 | $37.56M 10-K · filed 2014-08-01 | ||||
| 2012-02-26 | $9.14M 10-Q · filed 2013-04-04 | $17.94M derived: sum of 2 quarters · filed 2013-04-04 | $26.31M 10-Q · filed 2013-04-04 | $40.03M derived: sum of 4 quarters · filed 2013-08-07 | ||||
| 2011-11-27 | $8.80M 10-Q · filed 2013-01-04 | $17.18M 10-Q · filed 2013-01-04 | $30.90M derived: sum of 3 quarters · filed 2013-08-07 | $39.63M derived: sum of 4 quarters · filed 2013-08-07 | ||||
| 2011-08-28 | $8.38M 10-Q/A · filed 2013-01-02 | $22.09M derived: sum of 2 quarters · filed 2013-08-07 | $30.83M derived: sum of 3 quarters · filed 2013-08-07 | $39.16M derived: sum of 4 quarters · filed 2013-08-07 | ||||
| 2011-05-29 | $13.72M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $22.45M derived: sum of 2 quarters · filed 2013-08-07 | $30.78M derived: sum of 3 quarters · filed 2013-08-07 | $38.66M 10-K · filed 2013-08-07 | ||||
| 2011-02-27 | $8.73M 10-Q · filed 2012-03-28 | $17.06M derived: sum of 2 quarters · filed 2012-03-28 | $24.95M 10-Q · filed 2012-03-28 | |||||
| 2010-11-28 | $8.33M 10-Q · filed 2012-01-05 | $16.21M 10-Q · filed 2012-01-05 | ||||||
| 2010-08-29 | $7.88M 10-Q · filed 2011-10-05 | |||||||
| 2010-05-30 | $25.78M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |